Development of therapeutic cancer vaccines: Los Angeles Airport Renaissance Hotel, California, USA, April 27 - 29, 2004
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Basel [u.a.]
Karger
2004
|
| Schriftenreihe: | Developments in biologicals
116 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XII, 243 S. Ill., graph. Darst. 240 mm x 170 mm |
| ISBN: | 3805577362 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV019523070 | ||
| 003 | DE-604 | ||
| 005 | 20210702 | ||
| 007 | t | ||
| 008 | 041026s2004 gw ad|| |||| 10||| eng d | ||
| 015 | |a 04,N36,0449 |2 dnb | ||
| 016 | 7 | |a 97198591X |2 DE-101 | |
| 020 | |a 3805577362 |c Pb. : EUR 168.00 (freier Pr.), sfr 235.00 (freier Pr.) |9 3-8055-7736-2 | ||
| 024 | 3 | |a 9783805577366 | |
| 035 | |a (OCoLC)56524743 | ||
| 035 | |a (DE-599)BVBBV019523070 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE-BW | ||
| 049 | |a DE-12 |a DE-355 |a DE-11 | ||
| 050 | 0 | |a RC268.15 | |
| 082 | 0 | |a 614.5999 |2 22 | |
| 084 | |a XD 3300 |0 (DE-625)152554:12905 |2 rvk | ||
| 084 | |a XH 3205 |0 (DE-625)152888:12911 |2 rvk | ||
| 084 | |a XH 3900 |0 (DE-625)152896:13129 |2 rvk | ||
| 084 | |a 610 |2 sdnb | ||
| 245 | 1 | 0 | |a Development of therapeutic cancer vaccines |b Los Angeles Airport Renaissance Hotel, California, USA, April 27 - 29, 2004 |c vol. ed.: Fred Brown ... |
| 264 | 1 | |a Basel [u.a.] |b Karger |c 2004 | |
| 300 | |a XII, 243 S. |b Ill., graph. Darst. |c 240 mm x 170 mm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Developments in biologicals |v 116 | |
| 650 | 4 | |a Vaccins anticancéreux - Congrès | |
| 650 | 4 | |a Vaccins anticancéreux - Emploi en thérapeutique - Congrès | |
| 650 | 4 | |a Cancer Vaccines |v Congresses | |
| 650 | 4 | |a Cancer vaccines |v Congresses | |
| 650 | 4 | |a Cancer vaccines |x Therapeutic use |v Congresses | |
| 650 | 4 | |a Neoplasms |x drug therapy |v Congresses | |
| 650 | 4 | |a Neoplasms |x prevention & control |v Congresses | |
| 650 | 0 | 7 | |a Immunprophylaxe |0 (DE-588)4134312-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Impfstoff |0 (DE-588)4026655-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 2004 |z Los Angeles, Calif. |2 gnd-content | |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 1 | 1 | |a Immunprophylaxe |0 (DE-588)4134312-8 |D s |
| 689 | 1 | |C b |5 DE-604 | |
| 700 | 1 | |a Brown, Fred |d 1925-2004 |e Sonstige |0 (DE-588)171991923 |4 oth | |
| 830 | 0 | |a Developments in biologicals |v 116 |w (DE-604)BV013104325 |9 116 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=012901140&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-012901140 | ||
Datensatz im Suchindex
| _version_ | 1804132913719017472 |
|---|---|
| adam_text | Contents
Plenary Session
History of Tumour Vaccines and Novel Approaches for Preventive Cancer Vaccines 3
O. Finn
Are Cancer Vaccines Really the Same as Infectious Disease Vaccines ? 13
J. Petricciani
Introductory Overviews
Keynote Address 21
P. Noguchi
Combinatorial Vaccine Strategies and the Use of Molecular Arrays to Characterize T Cell Activation .. 27
J. Schlom, C. Palena, J.W. Greiner, K. Y. Tsang, D.W. Grosenbach,
H. Sabzevari, J.L Gulley, P.M. Men, E. Kass, J.W. Hodge
Session I
Regulatory Considerations in Tumour Vaccine Development 49
Moderators: P. Keegan (CBER, FDA, USA)
J. Furesz (Bureau of Biologies, Canada) Retired
J. Donohoe (Therapeutic Goods Administration, Australia)
Preclinical Safety Studies in the Development of Tumour Vaccines (Abstract) 51
DM. Essayan
Regulatory Expectations During Product Development for Tumour Vaccines 53
K. Kawakami, R.K. Puri
Lessons from Preventive Infectious Disease Vaccines 61
D.K.F. Chandler, K. Midthun, K.L Goldenthal
Clinical Development of Tumour Vaccines (Abstract) 67
P. Keegan
Panel Discussion 69
Session 11
Autologous and Allogeneic: Cellular and Acellular Tumour Vaccines 77
Moderators: D. Morton (John Wayne Cancer Institute, USA)
B.A. Fox (Earle A. Chiles Research Institute, USA)
P. Moingeon (Aventis Pasteur, France)
Characterization of Polyvalent Allogeneic Vaccines 79
D. Van Epps
IX
Defined Antigens and Allogeneic Tumour Lysates as Cancer Vaccines (Abstract) 91
M.A. Cheever
Manipulating the Host Response to Autologous Tumour Vaccines 93
J. Ma, C.H. Poehlein, S.M. Jensen, M.G. LaCelle, T.M. Moudgil, D. Ruttinger,
D. Haley, M.J. Goldstein, J.W. Smith III, B. Curti, H. Ross, E. Walker,
H.M. Hu, W.J. Urba, B.A. Fox
Autologous Heat Shock Protein Peptide Complexes for Vaccination Against
Cancer: From Bench to Bedside 109
A. Hoos, D.L. Levey, J.J. Lewis
Recombinant Cancer Vaccines Based on Viral Vectors 117
P. Moingeon
Vaccination of Cancer Patients with Tumour Antigens Recognized by T Lymphocytes (Abstract) .. 123
T.Boon
Characterization of Autologous and Allogeneic Tumour Cells 125
F. Borellini
Panel Discussion 133
Session 111
Dendritic Cells (DC) as Tumour Vaccines 145
Moderators: H. Streicher (NCI, NIH, USA)
U. Kalinke (Paul Ehrlich Institut, Germany)
/. Banchereau (Baylor Institute for Immunology Research, USA)
Dendritic Cells as Melanoma Vaccines 147
J. Banchereau, J. Fay, S. Paczesny, H. Ueno, M. Dhodapkar, A.K. Palucka
APC Vaccines: Product Characterization and Clinical Development (Abstract) 157
M.V.Peshwa
Clinical Trials with Dendritic Cells: an Update of Product Developments and
Clinical Trials (Abstract) 159
JJ.Mule
Dendritic Cell/Tumour Fusions Vaccine 161
D. Avigan
Therapeutic Vaccine Generated by Electrofusion of Dendritic Cells and Tumour Cells 169
H. Kuriyama, K. Shimizu, W. Lee, J. Kjaergaard, M.R. Parkhurst, PA. Cohen, S. Shu
Panel Discussion 179
Session IV
Preventive Tumour Vaccines, Clinical Strategies and Immunological Assessment
in Early Clinical Trials 187
Moderators /. Gust (University of Melbourne, Australia)
J.S. Robertson (NIBSC, U.K.)
O.J. Finn (University of Pittsburgh, USA)
E6, E7 and VLP Based Papillomavirus Vaccines for Prevention of Cervical Cancer (Abstract) .... 189
/. Frazer
Hepatitis C Vaccines to Prevent Liver Cancer (Abstract) 191
M. Houghton
CoVal™ Fusions: a Therapeutic Vaccine Platform Using Heat Shock Proteins to Treat Chronic Viral
Infection and Cancer 193
JR. Neefe, N.R. Chu, L Mizzen
lmmunotherapeutic Strategies for Melanoma: The Role of Anatomic Site in Vaccination
and Immune Monitoring (Abstract) 201
P.Hwu
X Contents
Assays for Monitoring a CEA Peptide Induced Immunological Response in
Dendritic Cell Trials (Abstract) 203
H.K. Lyerly
Precision Guiding of Cytolytic T Lymphocyte Responses (Abstract) 205
C.J.M. Melief, H. Dumortier, S. Zwaveling, D. Schuurhuis, G. van Mierlo, J.P. Medema,
F. Ossendorp, S. van der Burg, R. Offringa
Effective Peptide Vaccines for Melanoma (Abstract) 207
J.S. Weber
Immune Response to Postsurgical Adjuvant Active Immunotherapy with Canvaxin
Polyvalent Cancer Vaccine: Correlations with Clinical Course of Patients with
Metastatic Melanoma 209
D.L. Morton
Methods to Monitor Immune Response and Quality Control 219
T.L Whiteside
Panel Discussion 229
Contents XI
|
| any_adam_object | 1 |
| author_GND | (DE-588)171991923 |
| building | Verbundindex |
| bvnumber | BV019523070 |
| callnumber-first | R - Medicine |
| callnumber-label | RC268 |
| callnumber-raw | RC268.15 |
| callnumber-search | RC268.15 |
| callnumber-sort | RC 3268.15 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XD 3300 XH 3205 XH 3900 |
| ctrlnum | (OCoLC)56524743 (DE-599)BVBBV019523070 |
| dewey-full | 614.5999 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 614 - Forensic medicine; incidence of disease |
| dewey-raw | 614.5999 |
| dewey-search | 614.5999 |
| dewey-sort | 3614.5999 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02572nam a2200613 cb4500</leader><controlfield tag="001">BV019523070</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20210702 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">041026s2004 gw ad|| |||| 10||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">04,N36,0449</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">97198591X</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3805577362</subfield><subfield code="c">Pb. : EUR 168.00 (freier Pr.), sfr 235.00 (freier Pr.)</subfield><subfield code="9">3-8055-7736-2</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783805577366</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)56524743</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV019523070</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BW</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-11</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC268.15</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">614.5999</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 3300</subfield><subfield code="0">(DE-625)152554:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3205</subfield><subfield code="0">(DE-625)152888:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3900</subfield><subfield code="0">(DE-625)152896:13129</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Development of therapeutic cancer vaccines</subfield><subfield code="b">Los Angeles Airport Renaissance Hotel, California, USA, April 27 - 29, 2004</subfield><subfield code="c">vol. ed.: Fred Brown ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel [u.a.]</subfield><subfield code="b">Karger</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XII, 243 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield><subfield code="c">240 mm x 170 mm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Developments in biologicals</subfield><subfield code="v">116</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccins anticancéreux - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccins anticancéreux - Emploi en thérapeutique - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer Vaccines</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer vaccines</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer vaccines</subfield><subfield code="x">Therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">prevention & control</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Immunprophylaxe</subfield><subfield code="0">(DE-588)4134312-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">2004</subfield><subfield code="z">Los Angeles, Calif.</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Immunprophylaxe</subfield><subfield code="0">(DE-588)4134312-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="C">b</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brown, Fred</subfield><subfield code="d">1925-2004</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)171991923</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Developments in biologicals</subfield><subfield code="v">116</subfield><subfield code="w">(DE-604)BV013104325</subfield><subfield code="9">116</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=012901140&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-012901140</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 2004 Los Angeles, Calif. gnd-content |
| genre_facet | Konferenzschrift 2004 Los Angeles, Calif. |
| id | DE-604.BV019523070 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T20:00:23Z |
| institution | BVB |
| isbn | 3805577362 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-012901140 |
| oclc_num | 56524743 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR DE-11 |
| owner_facet | DE-12 DE-355 DE-BY-UBR DE-11 |
| physical | XII, 243 S. Ill., graph. Darst. 240 mm x 170 mm |
| publishDate | 2004 |
| publishDateSearch | 2004 |
| publishDateSort | 2004 |
| publisher | Karger |
| record_format | marc |
| series | Developments in biologicals |
| series2 | Developments in biologicals |
| spelling | Development of therapeutic cancer vaccines Los Angeles Airport Renaissance Hotel, California, USA, April 27 - 29, 2004 vol. ed.: Fred Brown ... Basel [u.a.] Karger 2004 XII, 243 S. Ill., graph. Darst. 240 mm x 170 mm txt rdacontent n rdamedia nc rdacarrier Developments in biologicals 116 Vaccins anticancéreux - Congrès Vaccins anticancéreux - Emploi en thérapeutique - Congrès Cancer Vaccines Congresses Cancer vaccines Congresses Cancer vaccines Therapeutic use Congresses Neoplasms drug therapy Congresses Neoplasms prevention & control Congresses Immunprophylaxe (DE-588)4134312-8 gnd rswk-swf Impfstoff (DE-588)4026655-2 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 2004 Los Angeles, Calif. gnd-content Krebs Medizin (DE-588)4073781-0 s Impfstoff (DE-588)4026655-2 s DE-604 Immunprophylaxe (DE-588)4134312-8 s b DE-604 Brown, Fred 1925-2004 Sonstige (DE-588)171991923 oth Developments in biologicals 116 (DE-604)BV013104325 116 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=012901140&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Development of therapeutic cancer vaccines Los Angeles Airport Renaissance Hotel, California, USA, April 27 - 29, 2004 Developments in biologicals Vaccins anticancéreux - Congrès Vaccins anticancéreux - Emploi en thérapeutique - Congrès Cancer Vaccines Congresses Cancer vaccines Congresses Cancer vaccines Therapeutic use Congresses Neoplasms drug therapy Congresses Neoplasms prevention & control Congresses Immunprophylaxe (DE-588)4134312-8 gnd Impfstoff (DE-588)4026655-2 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| subject_GND | (DE-588)4134312-8 (DE-588)4026655-2 (DE-588)4073781-0 (DE-588)1071861417 |
| title | Development of therapeutic cancer vaccines Los Angeles Airport Renaissance Hotel, California, USA, April 27 - 29, 2004 |
| title_auth | Development of therapeutic cancer vaccines Los Angeles Airport Renaissance Hotel, California, USA, April 27 - 29, 2004 |
| title_exact_search | Development of therapeutic cancer vaccines Los Angeles Airport Renaissance Hotel, California, USA, April 27 - 29, 2004 |
| title_full | Development of therapeutic cancer vaccines Los Angeles Airport Renaissance Hotel, California, USA, April 27 - 29, 2004 vol. ed.: Fred Brown ... |
| title_fullStr | Development of therapeutic cancer vaccines Los Angeles Airport Renaissance Hotel, California, USA, April 27 - 29, 2004 vol. ed.: Fred Brown ... |
| title_full_unstemmed | Development of therapeutic cancer vaccines Los Angeles Airport Renaissance Hotel, California, USA, April 27 - 29, 2004 vol. ed.: Fred Brown ... |
| title_short | Development of therapeutic cancer vaccines |
| title_sort | development of therapeutic cancer vaccines los angeles airport renaissance hotel california usa april 27 29 2004 |
| title_sub | Los Angeles Airport Renaissance Hotel, California, USA, April 27 - 29, 2004 |
| topic | Vaccins anticancéreux - Congrès Vaccins anticancéreux - Emploi en thérapeutique - Congrès Cancer Vaccines Congresses Cancer vaccines Congresses Cancer vaccines Therapeutic use Congresses Neoplasms drug therapy Congresses Neoplasms prevention & control Congresses Immunprophylaxe (DE-588)4134312-8 gnd Impfstoff (DE-588)4026655-2 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| topic_facet | Vaccins anticancéreux - Congrès Vaccins anticancéreux - Emploi en thérapeutique - Congrès Cancer Vaccines Congresses Cancer vaccines Congresses Cancer vaccines Therapeutic use Congresses Neoplasms drug therapy Congresses Neoplasms prevention & control Congresses Immunprophylaxe Impfstoff Krebs Medizin Konferenzschrift 2004 Los Angeles, Calif. |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=012901140&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV013104325 |
| work_keys_str_mv | AT brownfred developmentoftherapeuticcancervaccineslosangelesairportrenaissancehotelcaliforniausaapril27292004 |